Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland
Launched by UNIVERSITY OF ABERDEEN · Sep 28, 2017
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland" is studying a condition known as Takotsubo cardiomyopathy, which happens when extreme emotional or physical stress causes heart symptoms that look like a heart attack. Although the arteries are not blocked, this condition can still be very serious and may carry similar risks to a heart attack. The goal of this study, called the STARR study, is to find out how many cases of Takotsubo have occurred in Scotland since 2010 and to learn more about its causes and effects.
If you or someone you know has been diagnosed with Takotsubo cardiomyopathy, you could be eligible to participate in this study, as there are no specific age or gender restrictions. Participants will help researchers gather important information about this condition. The study is currently recruiting, and anyone who takes part can expect to provide information about their experiences with Takotsubo. This research is crucial for understanding how this condition affects people and could help improve future treatments.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients diagnosed with Takotsubo cardiomyopathy
- Exclusion Criteria:
- • NA
About University Of Aberdeen
The University of Aberdeen, a prestigious institution founded in 1495, is a leading center for research and education in healthcare and clinical sciences. With a commitment to advancing knowledge and improving patient outcomes, the university actively sponsors clinical trials that explore innovative treatments and therapies across various medical fields. Leveraging its interdisciplinary expertise and state-of-the-art facilities, the University of Aberdeen fosters collaborations with healthcare professionals and industry partners to enhance the quality of clinical research and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aberdeen, Scotland, United Kingdom
Patients applied
Trial Officials
Dana Dawson, MD, MRCP
Principal Investigator
University of Aberdeen
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials